Literature DB >> 8188295

The DCC gene: structural analysis and mutations in colorectal carcinomas.

K R Cho1, J D Oliner, J W Simons, L Hedrick, E R Fearon, A C Preisinger, P Hedge, G A Silverman, B Vogelstein.   

Abstract

DCC is a candidate tumor-suppressor gene encoding a protein with sequence similarity to cell adhesion molecules such as N-CAM. A set of overlapping YAC clones that contains the entire DCC coding region was isolated. Studies of this YAC contig showed that the DCC gene spans approximately 1.4 Mb. For elucidation of exon-intron structure, lambda phage clones containing all known coding sequences were isolated from a genomic library. These clones were used to demonstrate the existence of 29 DCC exons, and the sequences of the exon-intron boundaries were determined for each. Twenty-three polymorphic markers from chromosome 18 were then studied in a panel of primary colorectal tumors that had lost some, but not all, of chromosome 18. In most of these tumors, the region that was lost included DCC. Finally, Southern blot and PCR-based approaches were used to search for subtle mutations in several DCC exons. One tumor that had a point mutation in exon 28 was found, resulting in a proline to histidine substitution. A second tumor with a point mutation in intron 13 was also found. The regional map and genomic structure of DCC should provide the means to more extensively study DCC gene alterations and protein function in normal and neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8188295     DOI: 10.1006/geno.1994.1102

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  48 in total

Review 1.  Dependence receptors: between life and death.

Authors:  P Mehlen; C Thibert
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

2.  Genetic basis of variation in adenoma multiplicity in ApcMin/+ Mom1S mice.

Authors:  Jackie Haines; Victoria Johnson; Kevin Pack; Nirosha Suraweera; Predrag Slijepcevic; Erik Cabuy; Margaret Coster; Mohammad Ilyas; Jennifer Wilding; Oliver Sieber; Walter Bodmer; Ian Tomlinson; Andrew Silver
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

Review 3.  The angiogenic switch molecule, secreted FGF-binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinoma.

Authors:  Elena Tassi; Anton Wellstein
Journal:  Semin Oncol       Date:  2006-12       Impact factor: 4.929

4.  Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer.

Authors:  D C Fang; J R Jass; D X Wang
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

5.  Tumor angiogenesis: initiation and targeting - therapeutic targeting of an FGF-binding protein, an angiogenic switch molecule, and indicator of early stages of gastrointestinal adenocarcinomas -.

Authors:  Elena Tassi; Anton Wellstein
Journal:  Cancer Res Treat       Date:  2006-12-31       Impact factor: 4.679

Review 6.  APPL1: role in adiponectin signaling and beyond.

Authors:  Sathyaseelan S Deepa; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

7.  Lower frequency of allele loss on chromosome 18q in human breast cancer than in colorectal tumors.

Authors:  M Schenk; C Leib-Mösch; I U Schenck; M Jaenicke; S Indraccolo; H D Saeger; G Dallenbach-Hellweg; R Hehlmann
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

8.  The dependence receptor DCC requires lipid raft localization for cell death signaling.

Authors:  Céline Furne; Véronique Corset; Zoltán Hérincs; Nathalie Cahuzac; Anne-Odile Hueber; Patrick Mehlen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

9.  The genomics of colorectal cancer: state of the art.

Authors:  Andrew D Beggs; Shirley V Hodgson
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

10.  Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer.

Authors:  C Mamot; G Mild; J Reuter; U Laffer; U Metzger; L Terracciano; J-L Boulay; R Herrmann; C Rochlitz
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.